V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160017581 | 160019889 | 0 | 87.05 | Curative (C) | 2020-03-18 | 2020-03-18 | null | 02 | N | GEMCITABINE | 101161754 |
| 160017582 | 160019890 | null | 57.2 | Neo-adjuvant (N) | 2019-06-22 | 2019-10-23 | EW EuroEwing 2012 Arm B VC | 02 | N | ETOP 13-18 BEAT-MESO TRIAL | 101358586 |
| 160000341 | 160019891 | 1.6 | 103.2 | Palliative (P) | 2020-01-03 | 2020-01-04 | BEP 5 Day | 02 | N | NB HRNBL-1 ISOTRETINOIN | 100944148 |
| 160002009 | 160019892 | 1.45 | 114.6 | Palliative (P) | 2020-05-17 | 2020-06-19 | DACARBAZINE + GEMCITABINE | 02 | N | STS RHABDOMYOSARCOMA RMS 2005 IVA | 100169851 |
| 160002663 | 160019893 | 1.5 | 57.3 | Palliative (P) | 2020-07-22 | 2020-10-01 | WT SIOP 2002 01 post op Carbo, Etop | 02 | N | STS RHABDO RMS 2005 VIN CYCLO | 100494391 |
| 160003704 | 160019894 | 1.8 | 62.3 | 03 | 2016-11-19 | 2016-12-03 | Olaratumab | 02 | N | VINCRISTINE | 101329324 |
| 160005199 | 160019896 | 0 | 103.4 | null | null | 2019-12-01 | Bendamustine+Rituximab(Sub Courses) | 02 | null | IMATINIB | 100797738 |
| 160008433 | 160019897 | 1.7 | 66 | null | 2019-07-20 | 2020-01-17 | GemCarbo Days 1+8 | 01 | null | STS RHABDOMYOSARCOMA RMS 2005 VA | 100659790 |
| 160008630 | 160019898 | null | 84.7 | null | 2022-03-09 | 2022-04-06 | DACARBAZINE + GEMCITABINE | 02 | null | ETOPOSIDE + IFOSFAMIDE | 100288187 |
| 160008933 | 160019899 | 1.78 | 63 | null | 2017-07-22 | 2017-08-15 | EW EuroEwing 2012 Arm B VC | 02 | null | ETOPOSIDE + IFOSFAMIDE | 101078869 |
| 160009395 | 160019900 | null | null | null | 2018-12-17 | 2020-05-31 | PROMISE-MESO TRIAL | 2 | null | OLAPARIB | 100169012 |
| 160009742 | 160019901 | 0 | 106.8 | null | 2018-05-20 | 2018-05-27 | NB Rel CCLG guidelines Cyclo-Topotecan | 01 | null | DACTINOMYCIN + IFOSFAMIDE + VINCRISTINE | 101683016 |
| 160010408 | 160019903 | 1.66 | 16 | null | 2017-09-01 | 2017-11-17 | Trial Unspecified | 02 | null | PROMISE-MESO TRIAL | 101861151 |
| 160010801 | 160019905 | 1.73 | 87 | Curative (C) | 2017-09-08 | 2017-09-21 | EW EuroEwing 2012 Arm B VDC/IE | 02 | N | RUCAPARIB | 100508709 |
| 160010938 | 160019906 | 1.6 | 48 | Curative (C) | 2019-09-24 | 2019-10-26 | Olaparib | 02 | N | CISPLATIN + ETOPOSIDE | 101163903 |
| 160011377 | 160019907 | 0 | null | Curative (C) | 2021-01-23 | 2021-01-26 | CISPLATIN + ETOPOSIDE | 02 | N | CYCLOPHOSPHAMIDE | 100726833 |
| 160012860 | 160019908 | 1.74 | 99.8 | Palliative (P) | 2020-08-14 | 2020-08-18 | Bortezomib + Daratumumab | 01 | N | NB RELAPSED CYCLOPHOSPHAMIDE AND TOPOTECAN | 100453526 |
| 160013237 | 160019909 | 1.83 | 139 | Palliative (P) | 2019-02-26 | 2019-03-07 | Olaratumab | 02 | N | BEVACIZUMAB + CARBO + PACLITAXEL | 100446913 |
| 160013461 | 160019910 | 1.7 | 18.5 | Adjuvant (A) | 2019-12-16 | 2019-12-17 | CABOZANTINIB | 02 | N | RALTITREXED | 101452805 |
| 160013479 | 160019911 | 1.67 | 30 | Palliative (P) | 2020-09-21 | 2021-11-30 | NB Rel CCLG guidelines Cyclo-Topotecan | 01 | N | STS RHABDO RMS 2005 VIN CYCLO | 100037693 |
| 160014432 | 160019912 | 1.65 | 49.2 | null | 2020-04-20 | 2020-04-20 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | null | OLAPARIB | 101285374 |
| 160014891 | 160019913 | 1.54 | 50 | Palliative (P) | 2017-07-24 | 2018-02-27 | STS Rhabdomyosarco RMS 2005 IVADoVV | 02 | N | EW EUROEWING 2012 ARM B IE | 101812067 |
| 160015547 | 160019915 | 1.1 | 69.6 | Curative (C) | 2018-11-30 | 2019-01-22 | IVA | 02 | null | IPILIMUMAB + NIVOLUMAB | 101260596 |
| 160016067 | 160019916 | 1.78 | 95.3 | null | 2021-09-21 | 2022-04-16 | STS Rhabdomyosarcoma RMS 2005 IVA | 01 | null | NOT MATCHED | 100042257 |
| 160016351 | 160019917 | 1.72 | 19 | null | 2017-06-09 | 2017-07-31 | null | 02 | null | VIDE | 100433377 |
| 160016734 | 160019919 | 1.84 | 90 | Curative (C) | 2018-11-07 | 2018-11-07 | Cyclophosphamide PO +Vinorelbine IV | 01 | N | IRINOTECAN + TEMOZOLOMIDE | 100068510 |
| 160009398 | 160019920 | 1.63 | 91.8 | Curative (C) | 2017-06-09 | 2017-06-10 | STS Rhabdomyosarco RMS 2005 IVADoVV | 02 | null | RITUXIMAB | 101361877 |
| 160012676 | 160019921 | 0 | 70.2 | Palliative (P) | 2020-01-24 | 2020-01-30 | VINCRISTINE | 02 | N | GEMCITABINE | 101571023 |
| 160011485 | 160019993 | null | null | null | null | 2021-05-27 | null | null | null | CARBOPLATIN + PEMETREXED | 100908986 |
| 160011613 | 160019995 | null | null | null | null | null | null | null | null | CARBOPLATIN + PEMETREXED | 101323933 |
| 160011638 | 160019996 | null | null | null | null | 2021-04-17 | null | 02 | null | CARBOPLATIN + PEMETREXED | 101162460 |
| 160011646 | 160019997 | null | null | null | null | null | null | null | null | CARBOPLATIN + PEMETREXED | 101720413 |
| 160011689 | 160019998 | null | 60 | Palliative (P) | null | 2016-09-09 | Carboplatin + Pemetrexed | 02 | null | CARBOPLATIN + PEMETREXED | 101790619 |
| 160011798 | 160019999 | null | null | null | null | 2018-12-24 | null | null | null | CARBOPLATIN + PEMETREXED | 101828336 |
| 160011995 | 160020005 | null | null | null | null | 2022-01-13 | null | 02 | null | CARBOPLATIN + PEMETREXED | 100136868 |
| 160012141 | 160020009 | null | null | null | null | null | null | 02 | null | CARBOPLATIN + PEMETREXED | 100677858 |
| 160012407 | 160020013 | 1.82 | null | null | 2019-12-29 | 2020-01-05 | null | null | null | CARBOPLATIN + PEMETREXED | 101755774 |
| 160012426 | 160020014 | 1.76 | null | null | 2022-01-12 | 2022-02-08 | null | 02 | null | CARBOPLATIN + PEMETREXED | 100152789 |
| 160012455 | 160020016 | null | null | null | 2019-08-02 | 2019-08-02 | null | 2 | null | CARBOPLATIN + PEMETREXED | 100067373 |
| 160012492 | 160020019 | 1.75 | null | null | 2022-02-23 | 2022-03-12 | null | 02 | null | CARBOPLATIN + PEMETREXED | 100954195 |
| 160012830 | 160020026 | 1.8 | null | null | null | 2022-04-25 | null | 02 | null | CARBOPLATIN + PEMETREXED | 101446183 |
| 160012891 | 160020028 | 1.72 | 63 | Palliative (P) | null | 2019-01-19 | Carboplatin + Pemetrexed | 02 | N | CARBOPLATIN + PEMETREXED | 101578003 |
| 160013142 | 160020032 | 1.49 | null | null | null | 2016-11-24 | null | 2 | null | CARBOPLATIN + PEMETREXED | 101650471 |
| 160013174 | 160020033 | null | null | null | 2017-07-09 | 2017-07-11 | null | null | null | CARBOPLATIN + PEMETREXED | 100806418 |
| 160013301 | 160020035 | 1.72 | 56.4 | Palliative (P) | 2019-09-14 | 2019-09-29 | DOXORUBICIN | 02 | N | TRIAL UNSPECIFIED | 101445911 |
| 160013374 | 160020036 | 1.73 | 70.1 | Palliative (P) | null | null | DOXORUBICIN | 02 | N | DOXORUBICIN | 100159492 |
| 160013409 | 160020037 | 1.67 | 77 | null | 2020-09-10 | 2020-09-27 | VINORELBINE | 02 | null | VINORELBINE | 100716809 |
| 160013453 | 160020038 | 1.5 | 95.5 | null | 2022-01-09 | 2022-02-01 | DOXORUBICIN | 02 | null | DOXORUBICIN | 100513473 |
| 160013471 | 160020039 | 1.88 | 72.6 | Palliative (P) | 2021-10-04 | 2021-10-05 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101145327 |
| 160013477 | 160020040 | 1.72 | 88.6 | Palliative (P) | 2022-02-01 | 2022-02-16 | VINORELBINE | 02 | N | VINORELBINE | 100846649 |